Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: A randomized trial

JAMA

Volumn 286, Issue 23, 2001, Pages 2947-2955

  Kroenke, Kurt ^a   West, Suzanne L ^e,i   Swindle, Ralph ^b,d   Gilsenan, Alicia ^e   Eckert, George J ^a   Dolor, Rowena ^f   Stang, Paul ^g,i   Zhou, Xiao Hua ^a   Hays, Ron ^h   Weinberger, Morris ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d INDIANA UNIVERSITY   (United States)

^e RTI INTERNATIONAL   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Galt Associates   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

EID: 0035915312     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.23.2947     Document Type: Article

References (31)

1. Annual Rx survey
2. Fatal toxicity associated with antidepressant use in primary care
3. Safety and tolerability of the new antidepressants
4. A systematic review of newer pharmacotherapies for depression in adults: Evidence report summary: Clinical guidelines, II
5. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
6. Cost-effectiveness comparisons using "real world" randomized trials: The case of new antidepressant drugs
7. Initial antidepressant choice in primary care: Effectiveness and cost of fluoxetine vs tricyclic antidepressants
8. Performance of a five item mental health screening test
9. A multifaceted intervention to improve treatment of depression in primary care
10. Collaborative management to achieve treatment guidelines: Impact on depression in primary care
11. Telephone assessment of depression severity
12. Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 study
13. The PRIME-MD instrument
14. Validity and utility of a self-report version of PRIME-MD: The PHQ Primary Care Study
15. The Functional Status Questionnaire: Reliability and validity when used in primary care
16. A power primer
17. Rectangular confidence regions for the means of multivariate normal distributions
18. Detecting selection bias in randomized clinical trials
19. Worst-rank score analysis with informatively missing observations in clinical trials
20. Pharmacologic treatment of acute major depression and dysthymia: Clinical guideline, I
21. Treatments of depression and the functional capacity to work
22. Acute effects of fluoxetine versus placebo on functional health and well-being in late-life depression
23. Symptom indexes to assess outcomes of treatment for early prostate cancer
24. Antidepressant medication change in a clinical treatment setting: A comparison of the effectiveness of selective serotonin reuptake inhibitors